Building strong, investable Canadian life sciences companies.
adMare’s unique model helps to validate, incubate and accelerate growth. It is intentionally flexible, with supports adapted to meet the unique needs and stages of each opportunity.
Our approach
Validation
We provide meaningful pre-seed capital and drug development expertise to generate critical scientific data.
Incubation
We provide seed capital and early operational support to advance R&D, strengthen IP and enhance investment readiness.
Acceleration
We provide follow-on investment, a strong investor network and continued expert guidance to support Series fundraising and key inflection points.
adMare’s portfolio
adMare has helped build 54 companies that have raised $2.5 billion in real risk capital, have a combined value of $5.8 billion and created about 1000 jobs across Canada.
Our investment scope
adMare currently invests in highly-differentiated therapeutic innovations that address unmet patient needs.
Our investment criteria includes:
- Differentiation and competitive advantage of the technology
- Market opportunity
- Quality of the team
- Scope and strength of IP coverage
- Potential return on investment
- Impact of our investment
Partner with us
Tell us more about your innovation or company.
Our scientific and investment experts review every opportunity to determine fit and next steps.
